Homeless Overdose Prevention- Expansion (HOPE) for Veterans
This study, called Homeless Overdose Prevention- Expansion (HOPE), is testing ways to provide overdose education and naloxone (a medication that can reverse opioid overdose) to Veterans experiencing homelessness. This includes Veterans living in supportive housing programs. The study aims to see how well these programs can reach and be used by Veterans at risk for opioid overdose. Researchers will also look at how well the programs are put into practice over 12 months. You might be able to join if you are a Veteran, at least 18 years old, enrolled in the HUD-VASH program, and identified as being at risk for opioid overdose based on existing HOPE program information. The current recruitment status is unclear.
- Study design
- This interventional study plans to enroll 1200 participants. It compares two approaches to providing overdose education and naloxone distribution: a low-intensity and a high-intensity behavioral intervention.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will track how well the program reaches and is adopted by participants for 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Homeless Overdose Prevention- Expansion
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Amanda M. Midboe, PhD · PRINCIPAL_INVESTIGATOR · VA Palo Alto Health Care System, Palo Alto, CA
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Reach - VA administrative data12 months
Reach will be measured in terms of the proportion of Veterans who receive OEND, including overdose education and/or a naloxone prescription, using VA administrative data.
- Adoption - VA administrative data12 months
Adoption will be measured in terms of the proportion of VHA pharmacy and other prescriber staff who delivered OEND, using VA administrative data.
- Implementation - Electronic Data Capture12 months
Implementation will be measured in terms of adherence of sites to tailored implementation. Implementation fidelity will be captured using electronic data capture.
- Maintenance - Rapid Qualitative Interviews6-12 months
Maintenance will be assessed by the extent to which OEND has become part of routine organizational practices and policies, including clinical processes to maintain OEND. Maintenance will be assessed 6-12 months post-implementation using semi-structured interviews. Interviews will be conducted with HUD-VASH staff and measured using rapid qualitative methods and administrative data. Administrative data will be used to measure whether OEND continues to be provided in the maintenance period.